Brain pathology on imaging, etiologic classification, and the proportion of patients with cerebral palsy did not differ between treatment groups, except for 5 patients in the non-ACTH-treated group who had tuberous sclerosis (p < 0.001). This evidence concerns the gene POMC and tuberous sclerosis.